{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T04:54:44Z","timestamp":1777524884917,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.vaccine.2011.02.067","type":"journal-article","created":{"date-parts":[[2011,3,8]],"date-time":"2011-03-08T04:10:16Z","timestamp":1299557416000},"page":"3842-3849","source":"Crossref","is-referenced-by-count":29,"title":["Immunogenicity and safety of a measles\u2013mumps\u2013rubella\u2013varicella vaccine following a 4-week or a 12-month interval between two doses"],"prefix":"10.1016","volume":"29","author":[{"given":"H.C.","family":"R\u00fcmke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.P.","family":"Loch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Hoppenbrouwers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Vandermeulen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Malfroot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Helm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Douha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Willems","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.02.067_bib0005","first-page":"130","article-title":"Measles vaccines","volume":"79","author":"World Health Organization","year":"2004","journal-title":"Wkly Epidemiol Rec"},{"issue":"1","key":"10.1016\/j.vaccine.2011.02.067_bib0010","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s10198-003-0200-7","article-title":"The burden of varicella in Germany. Potential risks and economic impact","volume":"5","author":"Banz","year":"2004","journal-title":"Eur J Health Econ"},{"issue":"6","key":"10.1016\/j.vaccine.2011.02.067_bib0015","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s00431-005-1637-8","article-title":"Prospective surveillance of hospitalisations associated with varicella-zoster virus infections in children and adolescents","volume":"164","author":"Bonhoeffer","year":"2005","journal-title":"Eur J Pediatr"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2011.02.067_bib0020","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/S1201-9712(07)60022-8","article-title":"A new challenge for Europe: introducing a pediatric quadrivalent vaccine for measles, mumps, rubella, and varicella","volume":"11","author":"Ramet","year":"2007","journal-title":"Int J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2011.02.067_bib0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1086\/315714","article-title":"Varicella mortality: trends before vaccine licensure in the United States, 1970\u20131994","volume":"182","author":"Meyer","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.02.067_bib0030","author":"Centers for Disease Control and Prevention","year":"2007"},{"key":"10.1016\/j.vaccine.2011.02.067_bib0035","first-page":"51","article-title":"Mumps virus vaccines","volume":"82","author":"World Health Organization","year":"2007","journal-title":"Wkly Epidemiol Rec"},{"issue":"8","key":"10.1016\/j.vaccine.2011.02.067_bib0040","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/INF.0b013e318170bb22","article-title":"Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles\u2013mumps\u2013rubella\u2013varicella vaccine in healthy children during the second year of life","volume":"27","author":"Schuster","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2011.02.067_bib0045","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0264-410X(02)00459-0","article-title":"Reactogenicity and immunogenicity of a live attenuated tetravalent measles\u2013mumps\u2013rubella\u2013varicella (MMRV) vaccine","volume":"21","author":"Nolan","year":"2002","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2011.02.067_bib0050","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/01.inf.0000195626.35239.58","article-title":"Immunogenicity and safety of two doses of tetravalent measles\u2013mumps\u2013rubella\u2013varicella vaccine in healthy children","volume":"25","author":"Knuf","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.vaccine.2011.02.067_bib0055","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s15010-007-6337-z","article-title":"Safety and immunogenicity of early vaccination with two doses of tetravalent measles\u2013mumps\u2013rubella\u2013varicella (MMRV) vaccine in healthy children from 9 months of age","volume":"35","author":"Goh","year":"2007","journal-title":"Infection"},{"key":"10.1016\/j.vaccine.2011.02.067_bib0060","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.inf.0000172902.25009.a1","article-title":"Evaluation of a Quadrivalent measles, mumps, rubella and varicella vaccine in healthy children","volume":"24","author":"Shinefield","year":"2005","journal-title":"Peadiatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.02.067_bib0065","first-page":"314","article-title":"Pediatric combination vaccines: their impact on patients, providers, managed care organizations, and manufacturers","volume":"9","author":"Marcy","year":"2003","journal-title":"Am J Manage Care"},{"issue":"42","key":"10.1016\/j.vaccine.2011.02.067_bib0070","doi-asserted-by":"crossref","first-page":"7307","DOI":"10.1016\/j.vaccine.2007.08.017","article-title":"Universal mass vaccination against varicella in Germany using an MMRV combination vaccine with a two-dose schedule: an economic analysis","volume":"25","author":"Hammerschmidt","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2011.02.067_bib0075","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/01.inf.0000250689.09396.21","article-title":"Immunogenicity and safety of a second dose of measles\u2013mumps\u2013rubella\u2013varicella vaccine in healthy children aged 5 to 6 years","volume":"26","author":"Vesikari","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"10.1016\/j.vaccine.2011.02.067_bib0080","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/INF.0b013e3180616c8f","article-title":"Increasing coverage and efficiency of measles, mumps, and rubella vaccine and introducing universal varicella vaccination in Europe: a role for the combined vaccine","volume":"26","author":"Vesikari","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"RR-4","key":"10.1016\/j.vaccine.2011.02.067_bib0085","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recomm Rep"},{"issue":"5","key":"10.1016\/j.vaccine.2011.02.067_bib0090","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/01.inf.0000122606.88429.8f","article-title":"and the members of EuroVar the European Working Group on Varicella (EuroVar). A consensus paper: varicella vaccination of healthy children\u2014a challenge for Europe","volume":"23","author":"Rentier","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"14","key":"10.1016\/j.vaccine.2011.02.067_bib0095","first-page":"129","volume":"79","author":"World Health Organization","year":"2004","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2011.02.067_bib0100","first-page":"79","article-title":"Bek\u00e4mpfung der M\u00e4sern und konnatalen R\u00f6teln: WHO-Strategie in der Europ\u00e4ischen Region und aktueller Stand in Deutchland","volume":"10","author":"Robert Koch Institute","year":"2004","journal-title":"Epidemiol Bull"},{"issue":"47","key":"10.1016\/j.vaccine.2011.02.067_bib0105","first-page":"1058","article-title":"Simultaneous administration of varicella vaccine and other recommended childhood vaccine","volume":"50","author":"Centers for Disease Control","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"RR-1","key":"10.1016\/j.vaccine.2011.02.067_bib0110","first-page":"23","article-title":"Recommendations of the Advisory Committee on Immunization Practices (ACIP): General Recommendations on Immunization","volume":"43","author":"Centers for Disease Control","year":"1994","journal-title":"MMWR Recomm Rep"},{"issue":"5","key":"10.1016\/j.vaccine.2011.02.067_bib0115","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1128\/JCM.25.5.832-835.1987","article-title":"Comparison of fluorescent-antibody-to-membrane-antigen test, indirect immunofluorescence assay and a commercial enzyme-linked immunosorbent assay for determination of antibody to varicella-zoster virus","volume":"25","author":"Landry","year":"1987","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2011.02.067_bib0120","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1128\/CDLI.1.2.186-188.1994","article-title":"Comparison of three commercially available assays for detection of varicella-zoster virus antibody","volume":"1","author":"Martins","year":"1994","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2011.02.067_bib0125","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/biomet\/26.4.404","article-title":"The use of confidence or fiducial limits illustrated in the case of binomial","volume":"26","author":"Clopper","year":"1934","journal-title":"Biometrika"},{"issue":"3","key":"10.1016\/j.vaccine.2011.02.067_bib0130","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/archpedi.1969.02100040437004","article-title":"Evaluation of a live attenuated mumps vaccine (Jeryl Lynn). With observations on the optimal time for testing serologic response","volume":"118","author":"Brunell","year":"1969","journal-title":"Am J Dis Child"},{"issue":"477","key":"10.1016\/j.vaccine.2011.02.067_bib0135","first-page":"83","article-title":"An elementary school outbreak of varicella attributed to vaccine failure: policy implications","volume":"190","author":"Lee","year":"2004","journal-title":"J Infect Dis"},{"issue":"24","key":"10.1016\/j.vaccine.2011.02.067_bib0140","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa021662","article-title":"Outbreak of varicella at a day-care center despite vaccination","volume":"347","author":"Galil","year":"2002","journal-title":"NEJM"},{"issue":"24","key":"10.1016\/j.vaccine.2011.02.067_bib0145","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1056\/NEJMe020138","article-title":"Varicella vaccine\u2014are two doses better than one? (Editorials)","volume":"347","author":"Gershon","year":"2002","journal-title":"NEJM"},{"issue":"12","key":"10.1016\/j.vaccine.2011.02.067_bib0150","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S1473-3099(08)70282-2","article-title":"Measles, mumps, and rubella in Finland: 25 years of a nationwide elimination programme","volume":"8","author":"Peltola","year":"2008","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2011.02.067_bib0155","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1086\/591196","article-title":"Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks?","volume":"47","author":"Dayan","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2011.02.067_bib0160","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1016\/j.vaccine.2004.02.001","article-title":"Outbreak of mumps in a vaccinated child population: a question of vaccine failure?","volume":"22","author":"Vandermeulen","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.02.067_bib0165","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/528993","article-title":"Persistence of measles, mumps and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up","volume":"197","author":"Davidkin","year":"2008","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2011.02.067_bib0170","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00431-007-0506-z","article-title":"Immunogenicity and safety of a tetravalent measles\u2013mumps\u2013rubella\u2013varicella vaccine co-administered with a booster dose of a combined diphtheria\u2013tetanus\u2013acellular pertussis\u2013hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in healthy children aged 12\u201323 months","volume":"166","author":"Zepp","year":"2007","journal-title":"Eur J Pediatr"},{"issue":"4","key":"10.1016\/j.vaccine.2011.02.067_bib0175","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1358\/dot.2008.44.4.1210755","article-title":"A combination vaccine against measles, mumps, rubella and varicella","volume":"44","author":"Knuf","year":"2008","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.vaccine.2011.02.067_bib0180","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1016\/j.vaccine.2009.05.056","article-title":"Observational safety study of febrile convulsion following first dose MMRV vaccination in a management care setting","volume":"27","author":"Jacobsen","year":"2009","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11003021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11003021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T05:30:08Z","timestamp":1592371808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11003021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":36,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0264410X11003021"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.02.067","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}